Skip to Content

Zentiva S.A SCD

Rating as of

Morningstar’s Analysis

Valuation
Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Zentiva SA is a Romania based pharmaceutical company. It is engaged in the business of production and trade of human drugs and medication. The group generates key revenue from the sales of its products in Romania and internationally. The key therapeutic areas of the firm are the cardiovascular, central nervous system, gastrointestinal and metabolic disorders, anti-inflammatory and pain, blood disorders, urology, anti-infectives, respiratory, and others.

Contact
50, Theodor Pallady Boulevard, District 3
Bucharest, 032266, Romania
T +40 213047200
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 766